ReviewPHAGE (New Rochelle, N.Y.)2024
Thinking Phage Innovations Through Evolution and Ecology.
Review in PHAGE (New Rochelle, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gut virome-microbiome interactions across hosts and environments.NPJ biofilms and microbiomes · 2026Article
- Review
- Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, we conduct an interdisciplinary review of the potential of phage-based applications in light of current knowledge about phage evolution and ecology. Gaining an improved understanding of phages' ecology and evolutionary dynamics is crucial for recognizing both the benefits and limits of their usage, as well as potential negative downstream effects across different ecological milieus. As a reference, the history of the industrialization of antibiotics and the rise of antimicrobial resistance act as a reminder of the deep entanglement of both the evolvability capacities of micro-organisms and the history of human societies. Based on evolutionary biological parameters, we show that (1) virulent bacteriophages are best candidates for biocontrol, (2) best cocktails harbor complementary bacteriophages preventing bacterial cross-resistance, and (3) cure can also be considered with steer of bacterial bacteriophage-resistance evolution toward loss of virulence factor and/or increase in antibiotic susceptibility. A detailed review of what is known about the role of phages in vine cultivation and wine production finally serves as an example to show how it is important to consider site-specific rather than one-size-fits-all responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.